|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
|
WO1999055365A1
(en)
|
1998-04-30 |
1999-11-04 |
Cornell Research Foundation, Inc. |
Adenoviral vectors with tandem fiber proteins
|
|
CA2342396A1
(en)
*
|
1998-09-11 |
2000-03-23 |
Genvec, Inc. |
Alternatively targeted adenovirus
|
|
IL133032A
(en)
*
|
1998-11-20 |
2007-06-03 |
Introgene Bv |
Adenoviral gene delivery vectors provided with a tissue tropism for smooth muscle cells and /or endothelial cells
|
|
EP1020529B1
(en)
*
|
1998-11-20 |
2005-06-01 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
|
JP2000279178A
(ja)
*
|
1999-02-24 |
2000-10-10 |
Japan Found Cancer Res |
ウイルスベクター
|
|
DE19932688B4
(de)
*
|
1999-07-13 |
2009-10-08 |
Scil Proteins Gmbh |
Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
|
|
US7560527B1
(en)
|
1999-11-25 |
2009-07-14 |
Transgene S.A. |
Modified adenovirus fibre and uses
|
|
AU6368901A
(en)
*
|
2000-05-31 |
2001-12-11 |
Univ Saskatchewan |
Modified bovine adenovirus having altered tropism
|
|
CA2410981A1
(en)
*
|
2000-06-02 |
2001-12-06 |
Novartis Ag |
Adenovirus particles with mutagenized fiber proteins
|
|
CA2491805A1
(en)
*
|
2002-07-10 |
2004-01-22 |
Transgene S.A. |
Modified adenoviral fiber with ablated binding to cellular receptors
|
|
WO2005027711A2
(en)
*
|
2003-05-01 |
2005-03-31 |
University Of Washington |
Capsid-modified adenovirus vectors and methods of using the same
|
|
US7611868B2
(en)
*
|
2003-05-14 |
2009-11-03 |
Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Recombinant modified adenovirus fiber protein
|
|
DE10324447A1
(de)
|
2003-05-28 |
2004-12-30 |
Scil Proteins Gmbh |
Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin
|
|
GB0313132D0
(en)
*
|
2003-06-06 |
2003-07-09 |
Ich Productions Ltd |
Peptide ligands
|
|
WO2005030927A2
(en)
*
|
2003-09-23 |
2005-04-07 |
Uab Research Foundation |
Methods and compositions for in vivo inflammation monitoring
|
|
ES2871907T3
(es)
*
|
2004-01-23 |
2021-11-02 |
Msd Italia Srl |
Portadores de vacuna de adenovirus de chimpancé
|
|
DE102004049479A1
(de)
|
2004-10-11 |
2006-04-13 |
Scil Proteins Gmbh |
Proteinkonjugate zur Verwendung in Therapie, Diagnose und Chromatographie
|
|
US20070010016A1
(en)
*
|
2005-03-11 |
2007-01-11 |
Mccelland Alan |
Gene transfer with adenoviruses having modified fiber proteins
|
|
EP1893636A2
(en)
*
|
2005-06-17 |
2008-03-05 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Hepatitis c virus nucleic acid vaccine
|
|
WO2007094653A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles.
|
|
EP1925664A1
(en)
*
|
2006-11-15 |
2008-05-28 |
Scil proteins GmbH |
Artificial binding proteins based on a modified alpha helical region of ubiquitin
|
|
WO2009111738A2
(en)
|
2008-03-06 |
2009-09-11 |
Mayo Foundation For Medical Education And Research |
Single cycle replicating adenovirus vectors
|
|
BR112012014194A2
(pt)
|
2009-12-14 |
2017-01-10 |
Scil Proteins Gmbh |
um método para identificar proteínas ubiquitinas modificadas hetero-multiméricas com capacidade de ligação a ligandos
|
|
EP2721152B1
(en)
|
2011-06-15 |
2019-03-27 |
Navigo Proteins GmbH |
Dimeric binding proteins based on modified ubiquitins
|
|
CA2903582C
(en)
|
2013-03-14 |
2021-06-08 |
Salk Institute For Biological Studies |
Oncolytic adenovirus compositions
|
|
JP6738340B2
(ja)
|
2015-02-06 |
2020-08-12 |
ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ |
新規なｅｇｆｒ結合タンパク質
|
|
ES2916101T3
(es)
|
2015-07-16 |
2022-06-28 |
Navigo Proteins Gmbh |
Nuevas proteínas de unión a inmunoglobulina y su uso en la purificación por afinidad
|
|
JP2018520675A
(ja)
|
2015-07-20 |
2018-08-02 |
ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ |
ジユビキチン変異タンパク質をベースとした新規結合タンパク質及びその生成方法
|
|
JP7015551B2
(ja)
|
2016-02-23 |
2022-02-15 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現
|
|
WO2017147265A1
(en)
|
2016-02-23 |
2017-08-31 |
Salk Institute For Biological Studies |
High throughput assay for measuring adenovirus replication kinetics
|
|
JP2019526526A
(ja)
|
2016-05-04 |
2019-09-19 |
ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ |
ペプチドリンカーを含む化学的部分の部位特異的カップリングのための標的化合物
|
|
DK3497117T5
(da)
|
2016-08-11 |
2024-09-02 |
Navigo Proteins Gmbh |
Nye alkalisk stabile immunglobulin-bindende proteiner
|
|
US11352647B2
(en)
|
2016-08-17 |
2022-06-07 |
The Broad Institute, Inc. |
Crispr enzymes and systems
|
|
WO2018035387A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
CA3045892A1
(en)
|
2016-12-12 |
2018-06-21 |
Salk Institute For Biological Studies |
Tumor-targeting synthetic adenoviruses and uses thereof
|
|
WO2018191750A2
(en)
|
2017-04-14 |
2018-10-18 |
The Broad Institute Inc. |
Novel delivery of large payloads
|
|
WO2019135816A2
(en)
|
2017-10-23 |
2019-07-11 |
The Broad Institute, Inc. |
Novel nucleic acid modifiers
|
|
EP3706804B1
(en)
|
2017-11-07 |
2022-02-23 |
Navigo Proteins GmbH |
Fusion proteins with specificity for ed-b and long serum half-life for diagnosis or treatment of cancer
|
|
WO2019094983A1
(en)
|
2017-11-13 |
2019-05-16 |
The Broad Institute, Inc. |
Methods and compositions for treating cancer by targeting the clec2d-klrb1 pathway
|
|
BR112020019942A2
(pt)
|
2018-04-09 |
2021-01-26 |
Salk Institute For Biological Studies |
composições de adenovírus oncolítico com propriedades de replicação aprimoradas
|
|
WO2020131862A1
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Crispr-associated transposase systems and methods of use thereof
|
|
WO2020236972A2
(en)
|
2019-05-20 |
2020-11-26 |
The Broad Institute, Inc. |
Non-class i multi-component nucleic acid targeting systems
|
|
US12297426B2
(en)
|
2019-10-01 |
2025-05-13 |
The Broad Institute, Inc. |
DNA damage response signature guided rational design of CRISPR-based systems and therapies
|
|
US11149286B1
(en)
|
2020-08-17 |
2021-10-19 |
Mayo Foundation For Medical Education And Research |
Adenovirus vectors and methods for using adenovirus vectors
|
|
EP4503923A1
(en)
|
2022-04-04 |
2025-02-12 |
The Regents of the University of California |
Genetic complementation compositions and methods
|
|
WO2025072383A1
(en)
|
2023-09-25 |
2025-04-03 |
The Broad Institute, Inc. |
Viral open reading frames, uses thereof, and methods of detecting the same
|
|
WO2025097055A2
(en)
|
2023-11-02 |
2025-05-08 |
The Broad Institute, Inc. |
Compositions and methods of use of t cells in immunotherapy
|
|
WO2025129158A1
(en)
|
2023-12-15 |
2025-06-19 |
The Broad Institute, Inc. |
Engineered arc delivery vesicles and uses thereof
|
|
WO2025250808A1
(en)
|
2024-05-29 |
2025-12-04 |
The Brigham And Women’S Hospital, Inc. |
Anti-crispr delivery compositions and methods
|